News
New Research Demonstrates Potential of Jumpcode Genomics Depletion Technology to Improve Pandemic Response
SAN DIEGO, Calif. – May 1, 2023 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, together with the Translational Genomics Research Institute (TGen), part of City of Hope, today announced the results of a new study demonstrating the potential of Jumpcode Genomics depletion technology for improving future large-scale infectious […]
Jumpcode Genomics joins PacBio Compatible Program
Combination of Jumpcode Single Cell RNA Boost Kit and PacBio MAS-Seq for 10x Single Cell 3′ kit maximizes usable single cell RNA sequencing data SAN DIEGO, Calif. – January 11, 2023 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced it has joined the PacBio Compatible […]
Jumpcode Genomics Joins 10x Genomics’ Compatible Partner Program (CPP)
Powerful combination of Jumpcode Single Cell RNA Boost Kit and 10x Genomics Chromium Single Cell Gene Expression platform enables scientists to boost single cell RNA sequencing. SAN DIEGO, Calif. – November 30, 2022 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced a partnership with 10x […]
Jumpcode Genomics Unveils an Expanded CRISPRclean® RNA Depletion Portfolio to Boost Discovery
Innovative new technologies empower medical and biopharma scientists and researchers to extract greater insights from the transcriptome. SAN DIEGO, Calif. – October 18, 2022 Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today introduced an expanded portfolio of RNA depletion technologies to enable researchers to extract greater insights […]
New preprint posted on BioRxiv – A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics
We are excited to share a new preprint posted on BioRxiv today showing the use of Jumpcode’s CRISPRclean to achieve a 2x increase in library complexity and a 4x increase in isoform detection for single cell RNA-Seq. Our collaborators, including Eric Topol, MD and Amitabh Pandey at Scripps Research, found novel molecular characteristics, including inflammatory signatures in clinical […]
BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens.
BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens. This technology could aid in detecting any pathogen on day one of a public health emergency, providing better preparation for future pandemics. Jumpcode has partnered with […]